Sign In
Buy NTLA
Intellia Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 38.63. In total, the insiders bought 2.98M and sold 210.23K NTLA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
38.63 |
| ● Buy | 2.98M shares |
| ● Sell | 210.23K shares |
|
69% Buy Activity
Moderate Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Mar 02, 2026 Sell |
Basta James EVP, General Counsel |
1 211 Value: $16.7K |
||
|
Mar 02, 2026 Sell |
Clark Eliana EVP, Chief Technical Officer |
607 Value: $8K |
||
|
Mar 01, 2026 Buy |
Schultes Birgit C EVP, Chief Scientific Officer |
39 200 Value: $510.4K |
||
|
Mar 01, 2026 Buy |
Leonard John M President And CEO |
156 400 Value: $2.04M |
||
|
Mar 01, 2026 Buy |
Leonard John M President And CEO |
225 400 Value: $3.11M |
||
|
Mar 01, 2026 Buy |
Basta James EVP, General Counsel |
46 080 Value: $600.0K |
||
|
Mar 01, 2026 Buy |
Lebwohl David EVP, Chief Medical Officer |
14 204 Value: $195.7K |
||
|
Mar 01, 2026 Buy |
Dulac Edward J Iii EVP, Chief Financial Officer |
61 280 Value: $797.9K |
||
|
Mar 01, 2026 Buy |
Basta James EVP, General Counsel |
65 829 Value: $907.1K |
||
|
Mar 01, 2026 Buy |
Lebwohl David EVP, Chief Medical Officer |
9 943 Value: $129.5K |
||
|
Mar 01, 2026 Buy |
Dulac Edward J Iii EVP, Chief Financial Officer |
87 543 Value: $1.21M |
||
|
Mar 01, 2026 Buy |
Schultes Birgit C EVP, Chief Scientific Officer |
56 000 Value: $771.7K |
||
|
Mar 01, 2026 Buy |
Clark Eliana EVP, Chief Technical Officer |
7 353 Value: $95.7K |
||
|
Mar 01, 2026 Buy |
Clark Eliana EVP, Chief Technical Officer |
10 505 Value: $144.8K |
||
|
Mar 01, 2026 Buy |
Dube Michael P Vp, Chief Accounting Officer |
17 250 Value: $224.6K |
||
|
Jan 05, 2026 Sell |
Dube Michael P Vp, Chief Accounting Officer |
2 989 Value: $27.5K |
||
|
Jan 05, 2026 Sell |
Dulac Edward J Iii EVP, Chief Financial Officer |
6 379 Value: $58.8K |
||
|
Jan 05, 2026 Sell |
Clark Eliana EVP, Chief Technical Officer |
9 515 Value: $87.6K |
||
|
Jan 05, 2026 Sell |
Lebwohl David EVP, Chief Medical Officer |
11 903 Value: $109.6K |
||
|
Jan 05, 2026 Buy |
Cohen Fred E Director |
150 000 Value: $1.40M |
||
|
Jan 05, 2026 Sell |
Basta James EVP, General Counsel |
10 397 Value: $95.8K |
||
|
Jan 05, 2026 Sell |
Schultes Birgit C EVP, Chief Scientific Officer |
8 508 Value: $78.4K |
||
|
Jan 05, 2026 Sell |
Leonard John M President And CEO |
34 146 Value: $314.5K |
||
|
Dec 12, 2025 Buy |
Leonard John M President And CEO |
8 557 Value: $58.4K |
||
|
Dec 12, 2025 Buy |
Leonard John M President And CEO |
8 557 Value: $58.4K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
